CHELATION THERAPY (Investigator 161,
2015 March) History Theory The principal application for Chelation Therapy is the
treatment of
atherosclerosis, a disease of the arteries caused by the formation of
plaque
restricting the flow of blood. The chelating agent (EDTA) has the
capacity to
attach and bind the calcium and metal molecules, removing them from the
plaque
for eventual excretion from the body. As the inside diameter of the
blood
vessels is increased, this leads to greater blood flow.
Practice
Chelation Therapy is
administered by intravenous infusion directly into the bloodstream over
a
period of three to four hours. The full programme includes exercise,
diet,
vitamin and mineral supplements. Assessment The promotion of chelation therapy for circulatory
disorders has been disputed by the American Medical Association's House
of
Delegates who, in 1984, declared that "there was no evidence to support
the use of chelation therapy to treat arthritis, atherosclerosis,
cardiovascular disease, cancer, and several other conditions". In 1985
the
American Heart Foundation's Task Force on New and Unestablished
Therapies
endorsed this view. They concluded that there was no scientific
evidence to
demonstrate any benefit for CT against cardiovascular disease. No
significant
evidence of effectiveness has been published since that time. Green. 1993. Chelation Therapy: unproven claims and unsound
theories. Nutrition Forum.
10:33. Hatfield. 1985. Chelation Therapy, quackery or cure? ACSH News & Views. March
1985. Kastner, Mark. and Burroughs, Hugh. 1993. Alternative
Healing. Halcyon Publishing, Prevention Magazine
editors. 1992. Healing Remedies and Techniques. MJF Books, POB 0930,
Planetarium Station, NY 10024-0540. Zwicky, Hafner, Barrett and Jarvis 1993. Reader's
Guide to 'Alternative' Medicine. American
Medical Association,
Is alternative medicine and therapy as effective as modern science-based therapies?
Skeptics give their analysis on this website: https://investigatormagazine.net
|